Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,632 | -6,578 | -5,349 | -3,978 | -16,337 |
| Depreciation Amortization | 127 | 127 | 127 | 127 | 1,048 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,474 | N/A |
| Other Working Capital | 15 | 308 | -322 | 1,759 | -2,974 |
| Other Operating Activity | -74 | -112 | -156 | -1,683 | -2,865 |
| Operating Cash Flow | $-8,564 | $-6,255 | $-5,700 | $-2,301 | $-21,128 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -98 | 0 | 0 | 0 | -111 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-111 |
| Beginning Cash Position | 12,653 | 12,653 | 12,653 | 12,653 | 33,892 |
| End Cash Position | 4,089 | 6,398 | 6,953 | 10,352 | 12,653 |
| Net Cash Flow | $-8,564 | $-6,255 | $-5,700 | $-2,301 | $-21,239 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,564 | -6,255 | -5,700 | -2,301 | -21,128 |
| Free Cash Flow | -8,564 | -6,255 | -5,700 | -2,301 | -21,128 |